PHKG2
PHKG2 (phosphorylase kinase catalytic subunit gamma 2) is the catalytic subunit of phosphorylase b kinase, the enzyme that links neural and hormonal signals to glycogen breakdown. It is the liver and testis gamma isoform, formerly named phosphorylase kinase, gamma 2 (testis). Browse Assay Genie's current range of PHKG2 research reagents below, or read on for the biology behind the target.
PHKG2 is the catalytic subunit of phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis). It does so by phosphorylating, and thereby activating, glycogen phosphorylase. In vitro, the PHKG2 protein phosphorylates PYGM, and it may regulate glycogenolysis in the testis. The enzyme is classed as EC 2.7.11.19 and belongs to the protein kinase superfamily, within the CAMK Ser/Thr protein kinase family.
Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The gamma subunits contain the active site, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit is a calmodulin and mediates the dependence of the enzyme on calcium concentration. The gamma subunit exists as skeletal muscle and hepatic isoforms, and the PHKG2 gene encodes the hepatic isoform. Alternatively spliced transcript variants encoding different isoforms have been identified. Mouse and rat both have a Phkg2 ortholog.
HGNC places PHKG2 in the phosphorylase kinase subunits group and the phosphorylase kinase catalytic subunit gamma family. Mutations in the PHKG2 gene cause glycogen storage disease type 9C, also known as autosomal liver glycogenosis, which makes the protein a reference point for studies of hepatic glycogen metabolism.
PHKG2 activates glycogen phosphorylase, so it is central to studies of how glycogenolysis is controlled by neural and hormonal signals.
Mutations in the PHKG2 gene cause glycogen storage disease type 9C (autosomal liver glycogenosis), making it relevant to liver glycogenosis research.
As a CAMK family Ser/Thr kinase containing the active site of phosphorylase kinase, PHKG2 is used to study catalytic and regulatory subunit function.
PHKG2 may regulate glycogenolysis in the testis, giving a route to investigate tissue-specific energy metabolism.
PHKG2 is the catalytic subunit of phosphorylase b kinase. It phosphorylates and activates glycogen phosphorylase, mediating neural and hormonal regulation of glycogenolysis. In vitro it phosphorylates PYGM, and it may regulate glycogenolysis in the testis. The gamma subunits carry the enzyme's active site.
The gamma subunit has skeletal muscle and hepatic isoforms, and PHKG2 encodes the hepatic one. UniProt names the product the liver/testis isoform. HGNC previously listed the gene as phosphorylase kinase, gamma 2 (testis). Alternatively spliced transcript variants encoding different isoforms are also reported.
Mutations in PHKG2 cause glycogen storage disease type 9C, also called autosomal liver glycogenosis. Mouse and rat each have an ortholog named Phkg2, so rodent models can be used; check the datasheet of any product for its validated reactivity.
Other phosphorylase kinase subunits, glycogen phosphorylases and calmodulin-related targets in glycogen metabolism.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P15735; product specifications from Assay Genie datasheets.